Howard Berman - 28 Dec 2022 Form 3 Insider Report for Coya Therapeutics, Inc. (COYA)

Role
Chief Executive Officer, Director, 10%+ Owner
Signature
/s/ David Snyder, Attorney-in-Fact
Issuer symbol
COYA
Transactions as of
28 Dec 2022
Net transactions value
$0
Form type
3
Filing time
28 Dec 2022, 19:37:44 UTC
Next filing
17 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding COYA Common Stock, par value $0.0001 per share 939,338 28 Dec 2022 By Bertex LLC F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares reported reflect the 1 for 5.6955 stock split effected December 12, 2022.
F2 Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Remarks:

Exhibit 24--Power of Attorney